STTK
NASDAQ · Biotechnology
Shattuck Labs Inc
$7.42
+0.10 (+1.37%)
Financial Highlights (FY 2026)
Revenue
1.33M
Net Income
-64,985,191
Gross Margin
—
Profit Margin
-4,880.9%
Rev Growth
+15.4%
D/E Ratio
—
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | — | — | 47.5% | 47.5% |
| Operating Margin | -5,150.8% | -4,635.7% | 5.1% | 5.8% |
| Profit Margin | -4,880.9% | -4,636.9% | 3.7% | 4.6% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 1.33M | 1.16M | 31.76M | 28.92M |
| Gross Profit | — | — | 15.09M | 13.75M |
| Operating Income | -68,720,376 | -53,576,176 | 1.63M | 1.67M |
| Net Income | -64,985,191 | -50,664,130 | 1.18M | 1.33M |
| Gross Margin | — | — | 47.5% | 47.5% |
| Operating Margin | -5,150.8% | -4,635.7% | 5.1% | 5.8% |
| Profit Margin | -4,880.9% | -4,636.9% | 3.7% | 4.6% |
| Rev Growth | +15.4% | +15.4% | -3.0% | +24.7% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 0 | 0 | 82.62M | 102.31M |
| Total Equity | — | — | 173.07M | 148.25M |
| D/E Ratio | — | — | 0.48 | 0.69 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | -63,669,551 | -52,396,113 | 2.48M | 2.21M |
| Free Cash Flow | — | — | 903.7K | 487.2K |